Updated efficacy of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in patients with advanced renal cell carcinoma (aRCC) in the CLEAR study Meeting Abstract
| Authors: | Porta, C. G.; Eto, M.; Motzer, R. J.; De Giorgi, U.; Buchler, T.; Basappa, N. S.; Vidal, M. J.; Tjulandin, S.; Park, S. H.; Melichar, B.; Hutson, T.; Alemany, C.; McGregor, B.; He, C. S.; Perini, R.; Mody, K.; McKenzie, J.; Ebaid, B.; Choueiri, T. |
| Abstract Title: | Updated efficacy of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in patients with advanced renal cell carcinoma (aRCC) in the CLEAR study |
| Meeting Title: | 49th Annual Scientific Meeting of the Clinical Oncology Society of Australia (COSA) |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 18 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2022 Nov 2-4 |
| Meeting Location: | Brisbane, QLD, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2022-11-01 |
| Start Page: | 122 |
| End Page: | 123 |
| Language: | English |
| ACCESSION: | WOS:000871956500170 |
| PROVIDER: | wos |
| DOI: | 10.1111/ajco.13869 |
| Notes: | Meeting Abstract: 197 -- This meeting abstract was published under the "Poster Abstracts" section of the issue -- Source: Wos |
